Does Tracheal Suction During Extubation in Intensive Care Unit Decrease Functional Residual Capacity

June 3, 2026 updated by: University Hospital, Rouen

Little is known about the procedure of extubation of patients admitted in Intensive Care Units (ICU). In particular, effects of tracheal suction during extubation have never been evaluated. Tracheal suction induces alveolar derecruitment in sedated patients under mechanical ventilation and is a major source of pain.

The aim of this study was to evaluate the impact of tracheal suction during the extubation procedure of critically ill patients on the end-expiratory lung volume.

Study Overview

Detailed Description

This is a prospective, monocentric study, conducted in the surgical ICU of the university hospital of Rouen, France.

Sixty patients were expected to be randomized before extubation into two groups (ratio of 1:1) with different extubation protocols depending on whether tracheal suction was performed or not.

After oral information and collection of the non opposition of the patient to participate in the study, eligible patients were randomized (raio 1:1) in two groups: "tracheal suction" group or "no tracheal suction" group.

The allocation concealment was assured by enclosing assignments in sequentially numbered, opaque, sealed envelopes. Envelopes were opened after enrolment of each patient by the medical doctor in charged. Each envelope contained a number by a random allocation process using a computer-generated random block design (the randomization list was established by the local biostatistics unit before the beginning of the study).

Juste after inclusion, the 30 minutes standardized extubation protocol started and consisted of:

  • arterial blood gas analysis before the extubation (if there wasn't one dating less than 6 hours),
  • adjustment of the backrest of the bed in tilt to + 45 °,
  • tracheal suction 30 minutes before extubation (using a 14 french catheter, a vacuum of -200 mmHg systematically measured by a manometer XX),
  • the ventilator was then set on pressure support ventilation with pressure support level of 8 cmH2O and positive end-expiratory pressure (PEEP) of 5 cmH2O (FiO2 was adjusted for oxygen saturation by pulse oximetry between 95 and 98%) for 30 minutes,
  • installation of electrode belt for electrical impedance tomography (EIT) monitoring (Pulmovista 500, Dräger®) and calibration of the system,
  • aspiration of oropharyngeal secretions immediately before extubation with an oral cannula.
  • for "tracheal suction" group, extubation occured 30 minutes after inclusion. A tracheal suction (using a 14 french catheter, a vacuum of -200 mmHg) was performed at the same time as removal of the tracheal tube, after disconnection of the ventilator and after deflating the balloon of the tracheal tube.
  • for "no tracheal suction" group, extubation occured 30 minutes after inclusion and was performed after deflation of the balloon (and without further maneuver).
  • all patients underwent chest physical therapy between the 15th and 60th minutes following extubation.

No calculation of the number of subjects needed was possible (no data available concerning ΔEELI at extubation).

Data were described in the whole population and for each group ("tracheal suction" and "no tracheal suction") using the usual descriptive parameters: frequency for qualitative variables, median and interquartile range (IQR) for quantitative variables. Statistical analysis consisted of a nonparametric Mann and Whitney test for the quantitative variables and an exact Fisher test for the qualitative variables (using Statistical Analysis System software, version 9.4, Statistical Analysis System Institute; Cary, NC). The significance of the tests was retained for an α risk of 5%.

Study Type

Observational

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France, 76031
        • CHU de ROUEN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age of 18 years or more
  • hospitalization in the surgical ICU (whatever the cause of hospitalization)
  • under mechanical ventilation via a tracheal tube (oro or nasotracheal) for at least 24 hours
  • satisfying general criteria for mechanical ventilation weaning (described by the French Language Resuscitation Society)
  • having successfully completed a spontaneous breathing trial (among those described by the SRLF)
  • physiotherapist available during the first hour after extubation

Exclusion Criteria:

  • the presence of an electrical implantable medical device (pacemaker, automatic defibrillator, deep brain stimulation box)
  • body mass index (BMI) > 50
  • pregnancy
  • tracheal tube with subglottic suction channel
  • technical impossibility of monitoring by electrical impedance tomography (chest plaster, undrained pneumothorax, ...).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
tracheal suction
After a standardized protocol during the thirty minutes before extubation, extubation was performed with a standardized tracheal suction.
tracheal suctioning during extubation
no tracheal suction
After a standardized protocol during the thirty minutes before extubation, extubation was performed without tracheal suction.
No tracheal suctioning during extubation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ΔEELI 15
Time Frame: 15 minutes after extubation
The primary endpoint was the end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 15 minutes after extubation (ΔEELI 15). It happened so 45 minutes after inclusion (30 minutes of extubation protocol and 15 minutes after extubation)
15 minutes after extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ΔEELI H1
Time Frame: 60 minutes after extubation
The end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 60 minutes after extubation
60 minutes after extubation
ΔEELI H2
Time Frame: 120 minutes after extubation
The end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 120 minutes after extubation
120 minutes after extubation
Lowest oxygen saturation by pulse oximetry
Time Frame: 360 minutes after extubation
The lowest oxygen saturation by pulse oximetry observed within 6 hours after extubation
360 minutes after extubation
Oxygen flow
Time Frame: 360 minutes after extubation
The maximum oxygen flow administered within 6 hours after extubation (for oxygen saturation by pulse oximetry between 95 and 98%)
360 minutes after extubation
arterial partial pressure of oxygen
Time Frame: 360 minutes after extubation
Variation of arterial partial pressure of oxygen within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)
360 minutes after extubation
arterial oxygen saturation
Time Frame: 360 minutes after extubation
Variation of arterial oxygen saturation within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)
360 minutes after extubation
arterial partial pressure of carbon dioxide
Time Frame: 360 minutes after extubation
Variation of arterial partial pressure of carbon dioxide within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)
360 minutes after extubation
Respiratory rates
Time Frame: 360 minutes after extubation
Respiratory rates 1 hour and then, 6 hours after the extubation
360 minutes after extubation
Respiratory complication
Time Frame: 48 hours after extubation

Composite endpoint including the occurence of at least of of the following complication during 48 hours after extubation:

  • failure of extubation (need for reintubation)
  • new atelectasis after extubation (a chest x-ray was supposed to support the diagnosis)
  • the use of non-invasive ventilation for acute respiratory distress
  • new pneumonia after extubation
48 hours after extubation
Death
Time Frame: 48 hours after extubation
The occurence of death of the patient during 48 hours after extubation (whatever the cause of death was)
48 hours after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Benoît VEBER, MD, PhD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 27, 2015

Primary Completion (Actual)

August 31, 2016

Study Completion (Actual)

September 2, 2016

Study Registration Dates

First Submitted

March 6, 2018

First Submitted That Met QC Criteria

September 20, 2018

First Posted (Actual)

September 24, 2018

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

June 3, 2026

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill

Clinical Trials on tracheal suction

Subscribe